| Michal Ann Robinson, PHARMD | |
|
101 North Main Street, Prosperity, SC 29127 | |
| (803) 364-2310 | |
| (803) 364-2311 |
| Full Name | Michal Ann Robinson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 North Main Street, Prosperity, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558038604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 43030 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michal Ann Robinson, PHARMD 106 Hancock Ave, Spartanburg, SC 29302-4611 Ph: (803) 465-5323 | Michal Ann Robinson, PHARMD 101 North Main Street, Prosperity, SC 29127 Ph: (803) 364-2310 |
News Archive
A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.
Allergists realize people who are severely allergic to a food can experience great anxiety when encountering the food in any form.
Until only a few years ago, neurogenesis - the process of nerve cell development - was considered to be impossible in the adult brain. The textbooks asserted that dead nerve cells could not be replaced. Then researchers discovered regions in the forebrain in humans in which new nerve cells can be generated throughout life. These so-called GABAergic cells use gamma-aminobutyric acid (GABA), a neurotransmitter of the central nervous system.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).
› Verified 1 days ago
Dr. John Walter Pugh, PHAMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N Main St, Prosperity, SC 29127 Phone: 803-364-2310 | |
Dr. Karen Kibler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 North Main Street, Prosperity, SC 29127 Phone: 803-364-2310 | |
Carmen Monts, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N. Main St., Prosperity, SC 29127 Phone: 803-364-2310 Fax: 803-364-2311 | |
Dr. Dana Crawford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N Main Street, Prosperity, SC 29127 Phone: 803-364-2310 | |
Laura Montgomery, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N. Main St, Prosperity, SC 29127 Phone: 803-364-2310 Fax: 803-364-2311 | |
Dr. Kane Vaughn Summer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N Main Street, Prosperity, SC 29127 Phone: 803-364-2310 |